Cape Investment Advisory’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Cape Investment Advisory's ELV Position: Q2 2026 in Review
Cape Investment Advisory reduced its Elevance Health (ELV) stake by 11% in Q2 2026, selling an estimated $189K and leaving 3,955 shares worth $1.53M. The position accounts for 0.41% of the portfolio, ranked #46.
Cape Investment Advisory first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.65M in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Cape Investment Advisory held 3,955 shares of Elevance Health worth $1.53M as of Q2 2026.
- Cape Investment Advisory sold 510 Elevance Health shares in Q2 2026, an estimated $189K.
- Elevance Health made up 0.41% of Cape Investment Advisory's portfolio in Q2 2026, its #46 holding.
- Cape Investment Advisory first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
- Cape Investment Advisory's Elevance Health position peaked at $1.65M in Q1 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.